Uncertainty persists regarding whether drugs that lower sugar reduce the risk of heart attack, with some concerns that diabetes drugs...
Read moreNovartis has invited 60 selected students from leading international universities in 21 countries to its headquarters in Switzerland for the...
Read moreThe European Medicines Agency (EMA) and the United States Food and Drug Administration (US FDA) have published a joint question-and-answer...
Read moreThe U.S. Food and Drug Administration has approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an...
Read moreNovartis is the first company to earn global CEO Cancer Gold Standard accreditation by the non-profit organization CEO Roundtable on...
Read moreNovartis has announced that results of a global Phase III study showed that Afinitor® (everolimus) did not extend overall survival...
Read moreChemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural "endocannabinoids" without gastrointestinal side effects,...
Read moreGlaxoSmithKline (GSK) has increased its commitment to the GAVI Alliance to provide vaccines to developing countries, helping to protect millions...
Read moreSmall proteins called peptides that consist of 10 to 50 amino acids are being studied as cancer vaccines and as...
Read moreA team of University of California, San Diego researchers has designed new compounds that mimic those naturally used by the...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
